Title and Organization:
Amy is the co-founder and CEO of Vineti, which creates next-generation technology to drive and scale high-value medicine. From production to commercial systems, Vineti digitizes and orchestrates the end-to-end process needed for high value therapies to reach everyone who needs them. Previously, Amy was managing director at GE Ventures, General Electric’s venture capital subsidiary, where she focused on creating new healthcare businesses. In addition to venture investments, Amy drove growth strategy for new business creation portfolio companies as well as scoping and seeding independent business opportunities. Amy has also been chief business officer at Navigenics, a genomics company sold to Life Technologies in 2012. Before that, she co-founded and was the executive director of Proposition 71, California's $3 billion stem cell research initiative passed in 2004, as well as chief of staff at the resulting state grant oversight agency. Earlier in her career, Amy was one of the first employees at E-Loan, Inc., the first online consumer mortgage company. She stayed with that company through its IPO. She also worked for the World Bank Group to scale and deliver leapfrog technologies to developing economies. Amy holds an MBA and master’s and bachelor’s degree in English from Stanford University. She is also a Coro Fellow and an Aspen Institute Socrates Fellow. Amy is a Fellow of the second class of the Health Innovators Fellowship and a member of the Aspen Global Leadership Network.